New Severe Asthma Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved Cinqair (reslizumab) to manage severe asthma.
Could Colds Be Behind Asthma Hospitalizations?
Right after schools reopen after break could be the most dangerous time of year for children with asthma, new evidence suggests. And the reason why may surprise you.
A New Rx for Chronic Sinusitis
Scientists don't know exactly what causes nasal polyps to grow. But they may have developed an effective treatment for these bothersome growths.
Vitamin D in Moms-to-Be: The Effect on Kids' Asthma
Could the vitamin D in mom's diet during pregnancy affect her children's future health? Regarding asthma, that question might have been answered.
The Asthma-Shingles Connection
Ever had chickenpox? If so, you're at risk of shingles. But you may be at an even higher risk if you also have this common condition.
The Asthma-Migraine Connection
If you have asthma, you may be more likely to develop another common condition.
A New Option for Severe Asthma
Patients with severe asthma may soon have another treatment option to add to their current medications.
OK for New Asthma Rx
The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older.
New Test May Catch Asthma Early
A new diagnostic tool may help millions of Americans breathe a little easier.
The Pill That Could Stop Asthma Attacks
Asthma patients who find themselves reaching for their inhalers all too often may now have another treatment option — in the form of a pill.